Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Jan 15, 2025
Date Accepted: Aug 31, 2025

The final, peer-reviewed published version of this preprint can be found here:

Daily Dietary Sodium Intake Among Clinical Trial Participants Recruited From a University Health System or a Federally Qualified Health Center: Secondary Analysis of Baseline Participant Characteristics

Rubick GV, Dorsch MP, Hummel S, Basu T, Luff E, Warden K, Giacalone M, Bailey S, Newman MW, Skolarus LE, Nallamothu BK, Golbus JR

Daily Dietary Sodium Intake Among Clinical Trial Participants Recruited From a University Health System or a Federally Qualified Health Center: Secondary Analysis of Baseline Participant Characteristics

JMIR Cardio 2025;9:e71343

DOI: 10.2196/71343

PMID: 40997343

PMCID: 12463386

Daily Dietary Sodium Intake among Clinical Trial Participants Recruited from a University Health System or a Federally Qualified Health Center: A Secondary Analysis of Baseline Participant Characteristics

  • Gabriella VanAken Rubick; 
  • Michael P Dorsch; 
  • Scott Hummel; 
  • Tanima Basu; 
  • Evan Luff; 
  • Kimberly Warden; 
  • Michael Giacalone; 
  • Sarah Bailey; 
  • Mark W Newman; 
  • Lesli E Skolarus; 
  • Brahmajee K Nallamothu; 
  • Jessica R Golbus

ABSTRACT

Background:

Clinical trials increasingly focus on diverse recruitment based on demographic factors and health-related social needs.

Objective:

We sought to understand the impact of demographic factors and health-related social needs on dietary sodium intake in a contemporary trial.

Methods:

The myBPmyLife study is a prospective, randomized-controlled trial designed to evaluate a mobile health (mHealth) intervention to lower blood pressure through increased physical activity and lower sodium food choices. Hypertensive participants recruited from a university health system and federally qualified health center (FQHC) completed a baseline sodium screener. Univariable and multivariable models evaluated the association between sodium intake at baseline–a key inclusion criterion–and participant characteristics.

Results:

Of the 600 included participants, 96 (16.0%) were from the FQHC. Mean age was 60.1 (SD 13.5) years; 48.2% were women, and 13.0% were Black. Notable differences were seen between sites: FQHC participants were, on average, 14.6 years younger than university participants, more likely to be Black (44.8% versus 6.9%), and 8.5 times more likely to have difficulty paying for their health-related social needs. Sodium intake at baseline was significantly higher for FQHC participants (mean difference 381.1 mg/day; 95% CI 84.5 to 677.7; P=.012). Adjustments for demographic characteristics and health-related social needs mitigated differences in sodium intake between sites.

Conclusions:

In this clinical trial of an mHealth intervention, we found important participant differences in demographics and health-related social need-related factors based on the site of enrollment. As clinical trials recruit for diversity based on demographic characteristics, they may also benefit from diversifying enrollment sites to ensure truly representative populations. Clinical Trial: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05154929.


 Citation

Please cite as:

Rubick GV, Dorsch MP, Hummel S, Basu T, Luff E, Warden K, Giacalone M, Bailey S, Newman MW, Skolarus LE, Nallamothu BK, Golbus JR

Daily Dietary Sodium Intake Among Clinical Trial Participants Recruited From a University Health System or a Federally Qualified Health Center: Secondary Analysis of Baseline Participant Characteristics

JMIR Cardio 2025;9:e71343

DOI: 10.2196/71343

PMID: 40997343

PMCID: 12463386

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.